A collaborative effort between researchers from Uganda, Tanzania, the US, Spain, and Denmark has resolved a longstanding question in malaria research: Do individuals living in regions with continuous malaria transmission develop broadly neutralizing antibodies (BnAbs) against the malaria parasite? The answer is yes.
Researchers at the Ragon Institute of Mass General Brigham, MIT, and Harvard have uncovered critical insights into how aging impairs the immune system’s ability to fight cancer.
This study, published in Immunity on August 30, used a non-human primate model to demonstrate that previous Mtb infection leads to a durable, protective immune response that is dependent on CD4+ T cells.
MIT researchers find that the first dose primes the immune system, helping it to generate a strong response to the second dose, a week later.
We are deeply saddened to announce the passing of Ragon Institute faculty member Todd M. Allen, PhD, a pioneering researcher in T cell immunotherapy and HIV evolution and transmission.
Researchers at the University of Amsterdam, in collaboration with the Batista Lab at the Ragon Institute, have developed a potential new approach for an HIV vaccine.
Researchers at the Ndhlovu Lab, part of the Ragon Institute and the Africa Health Research Institute (AHRI), have completed a significant study on the safety and practicality of lymph node excisions for HIV cure research in South Africa.
For media inquiries, please contact ragoncommunications@mgh.harvard.edu.
The Ragon Institute of Mass General, MIT, and Harvard brings together scientists and engineers from diverse fields to better understand the immune system and support human health.
The Administrative and Operations team manages the Ragon’s operations, administrative, and logistical functions.
Our collaborative ethos applies to every aspect of our Institute, and we are committed to being an engaged and involved member of the communities we are fortunate to be a part of.